Additionally, the Kaplan–Meier survival and correlation analyses indicated that elevated SUCLG2 expression levels were significantly positively correlated with poor overall survival rates in patients with glioma (Fig. 1D, E). Here, SUCLG2 is linked to central nervous system cancer.